Erlanger Health Signs Intent to Join Prisma Health System

Erlanger Health has signed a non-binding letter of intent with Prisma Health, a nonprofit health system based in Greenville, South Carolina, to become part of that system. The proposed deal could include $2 billion in strategic capital investments over 15 years. Erlanger leaders say the partnership is intended to strengthen the Chattanooga-based system while keeping its local focus, and current patients are not expected to see immediate changes.

Why the timing matters for Chattanooga

The move comes as Erlanger seeks to secure long-term resources without altering day-to-day operations for patients in the immediate term. Leaders have emphasised that the Chattanooga-based system would retain its local focus even as it joins a larger regional network. If the partnership proceeds, Erlanger's CEO Jim Coleman would stay on as regional CEO for East Tennessee, leading what would become Prisma Health East Tennessee.

Approvals still required

Any final agreement still needs approvals from Erlanger's board, the Erlanger Health Oversight Panel, the Hamilton County Commission, and state and federal regulators. These steps determine whether the non-binding letter of intent advances to a completed transaction. The process involves review by multiple local oversight bodies in addition to broader regulatory checks.

What happens next

With the letter of intent now signed, attention turns to the sequence of board, panel, commission and regulatory reviews. Erlanger leaders have stated the partnership aims to strengthen the system while preserving its local character. Patients are not expected to face immediate changes during this evaluation period. Further details on timelines or outcomes will depend on the decisions made by the required approving bodies.